Emmanuel Bergot

6.2k total citations · 1 hit paper
101 papers, 2.5k citations indexed

About

Emmanuel Bergot is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Emmanuel Bergot has authored 101 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 17 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in Emmanuel Bergot's work include Pulmonary Hypertension Research and Treatments (24 papers), Lung Cancer Treatments and Mutations (15 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers). Emmanuel Bergot is often cited by papers focused on Pulmonary Hypertension Research and Treatments (24 papers), Lung Cancer Treatments and Mutations (15 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers). Emmanuel Bergot collaborates with scholars based in France, Canada and Switzerland. Emmanuel Bergot's co-authors include Gérard Zalcman, Marc Humbert, Olivier Sitbon, David Montani, Xavier Jaïs, Vincent Cottin, Guénaëlle Levallet, Arnaud Bourdin, Gérald Simonneau and François Picard and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Emmanuel Bergot

97 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

2017 441 citations Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emmanuel Bergot France	26	1.8k	770	423	366	345	101	2.5k
Murali M. Chakinala United States	28	1.2k 0.7×	583 0.8×	537 1.3×	185 0.5×	1.3k 3.8×	97	2.5k
Colas Tchérakian France	17	1.3k 0.8×	356 0.5×	173 0.4×	191 0.5×	288 0.8×	41	1.7k
Miguel Ángel Gómez Sánchez Spain	14	3.2k 1.8×	2.0k 2.6×	519 1.2×	267 0.7×	491 1.4×	46	3.9k
Paul Bishop United Kingdom	22	749 0.4×	437 0.6×	286 0.7×	332 0.9×	314 0.9×	58	2.0k
Julie Vincent France	28	828 0.5×	494 0.6×	867 2.0×	310 0.8×	623 1.8×	78	3.3k
Shigetoshi Yoshida Japan	33	1.9k 1.1×	213 0.3×	250 0.6×	315 0.9×	848 2.5×	132	3.1k
Manfred Hummel Germany	30	563 0.3×	1.5k 1.9×	603 1.4×	450 1.2×	2.5k 7.3×	121	4.4k
Silvia Laura Bosello Italy	27	585 0.3×	173 0.2×	436 1.0×	249 0.7×	222 0.6×	97	2.3k
Stephen M. Lagana United States	22	500 0.3×	428 0.6×	387 0.9×	714 2.0×	615 1.8×	71	2.1k
Akio Mimori Japan	28	384 0.2×	119 0.2×	379 0.9×	233 0.6×	339 1.0×	117	2.1k

Countries citing papers authored by Emmanuel Bergot

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Bergot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Bergot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Bergot more than expected).

Fields of papers citing papers by Emmanuel Bergot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Bergot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Bergot. The network helps show where Emmanuel Bergot may publish in the future.

Co-authorship network of co-authors of Emmanuel Bergot

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Bergot. A scholar is included among the top collaborators of Emmanuel Bergot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Bergot. Emmanuel Bergot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergot, Emmanuel, et al.. (2025). NDR2 kinase: A review of its physiological role and involvement in carcinogenesis. International Journal of Biological Macromolecules. 311(Pt 1). 143656–143656. 1 indexed citations

Levallet, Guénaëlle, Christian Créveuil, Solenn Brosseau, et al.. (2025). MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial. Translational Oncology. 61. 102520–102520. 1 indexed citations

Douane, Fréderic, F. Thouveny, Antoine Bouvier, et al.. (2023). Pulmonary Artery Embolization in the Management of Hemoptysis Related to Lung Tumors. Journal of Personalized Medicine. 13(11). 1597–1597. 3 indexed citations

Boucly, Athénaïs, Vincent Cottin, Hilario Nunès, et al.. (2017). Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. European Respiratory Journal. 50(4). 1700465–1700465. 91 indexed citations

Blischak, John, Ludovic Tailleux, Marsha Myrthil, et al.. (2017). Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells. Scientific Reports. 7(1). 5702–5702. 8 indexed citations

Créveuil, Christian, Fabrice Bauer, Farzin Beygui, et al.. (2017). Heart rate and risk of death among patients with Pulmonary Hypertension: A 12-lead ECG analysis. Respiratory Medicine. 132. 42–49. 8 indexed citations

Girerd, Barbara, Andrei Seferian, Katrina Campbell, et al.. (2016). Pulmonary complications of type 1 neurofibromatosis. Revue des Maladies Respiratoires. 33(6). 460–473. 14 indexed citations

Bergeron, Anne, Sylvie Chevret, Karine Chagnon, et al.. (2015). Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation. American Journal of Respiratory and Critical Care Medicine. 191(11). 1242–1249. 64 indexed citations

Roule, Vincent, Damien Legallois, Ziad Dahdouh, et al.. (2015). Antecubital vs Femoral Venous Access for Right Heart Catheterization: Benefits of a Flashback. Canadian Journal of Cardiology. 31(12). 1497.e1–1497.e6. 15 indexed citations

10.

Cattoir, Vincent, et al.. (2014). Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulmonary Medicine. 14(1). 137–137. 38 indexed citations

11.

Bergot, Emmanuel, Olivier Sitbon, Vincent Cottin, et al.. (2014). Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry. International Journal of Cardiology. 172(3). 561–567. 22 indexed citations

12.

Bergot, Emmanuel, Guénaëlle Levallet, Katrina Campbell, et al.. (2013). Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy. European Respiratory Review. 22(130). 565–576. 18 indexed citations

13.

Delcroix, Marion, Gérald Simonneau, Emmanuel Bergot, et al.. (2013). Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension. European Respiratory Journal. 42(Suppl 57). P4080–P4080. 1 indexed citations

14.

Fraipont, Florence de, Guénaëlle Levallet, Christian Créveuil, et al.. (2012). An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial. Clinical Cancer Research. 18(10). 2976–2986. 46 indexed citations

15.

Levallet, Guénaëlle, Emmanuel Bergot, Martine Antoine, et al.. (2012). High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway. Molecular Cancer Therapeutics. 11(5). 1203–1213. 74 indexed citations

16.

Bergot, Emmanuel. (2011). [Epidemiology and mechanisms of pneumonia in adults].. PubMed. 61(8). 1064–70. 3 indexed citations

17.

Sitbon, Olivier, Azzedine Yaïci, Laurence Rottat, et al.. (2011). The changing picture of patients with pulmonary arterial hypertension (PAH) in France. European Respiratory Journal. 38(Suppl 55). 4913–4913. 3 indexed citations

18.

Zalcman, Gérard, Emmanuel Bergot, & Emmanuèle Lechapt. (2010). Update on nonsmall cell lung cancer. European Respiratory Review. 19(117). 173–185. 16 indexed citations

19.

Wislez, Marie, Emmanuel Bergot, Martine Antoine, et al.. (2001). Acute Respiratory Failure Following HAART Introduction in Patients Treated for Pneumocystis carinii Pneumonia. American Journal of Respiratory and Critical Care Medicine. 164(5). 847–851. 97 indexed citations

20.

Maître, Bernard, Samir Jaber, Salvatore Maurizio Maggiore, et al.. (2000). Continuous Positive Airway Pressure during Fiberoptic Bronchoscopy in Hypoxemic Patients. American Journal of Respiratory and Critical Care Medicine. 162(3). 1063–1067. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact